Create a narrative

MiMedx Group Community

NasdaqCM:MDXG Community

1 Narratives written by author
0 Comments on narratives written by author
14 Fair Values set on narratives written by author

Create a narrative

AN

AnalystConsensusTarget

AnalystConsensusTarget

Consensus Narrative from 5 Analysts

EpiFix's Japanese Success And HELIOGEN Adoption Will Strengthen Future Prospects

Key Takeaways MiMedx anticipates increased revenue and market share through the implementation of pending LCDs and product innovation in HELIOGEN. International expansion and innovations like EpiFix and MiMedx Connect are crucial for enhancing revenue, margins, and customer relationships.

US$12.00

FV

41.9% undervalued

10.11%

Revenue growth p.a.

0

0

13

7 days ago